A mild anticoagulant, non specific immune stimulant, and regenerator of down regulated antioxidant function
Vitamin E has several documented anticancer properties:
(a) Cancer rather regularly induces an altered blood coagulation tendency with a heightened tendency to clot. Unexplained venous clotting (thrombosis) in an older patient frequently signals an undetected cancer. Seymore Ochsner, M.D. at the Ochsner Clinic in New Orleans, LA, popularized the use of vitamin E to prevent the vein thrombosis following surgery. Post surgical thrombosis may lead to deadly pulmonary emboli or other severe complications of major surgery.
Cancer colonies may protect themselves from phagocytosis by macrophages or attack by NK cells by spinning a cocoon-like coat of coagulated protein around themselves, much as hive moth larvae protect themselves from bee attacks as they burrow through the cells of a honey bee hive destroying everything in their path. Vitamin C or E, by decreasing the predisposition of blood to clot, “leans against” the pathophysiologic adaptation of the cancer colony.
(b) Vitamin E is the principle antioxidant of the fatty components (“lipid compartment”) of the body. The body’s own synthesized antioxidant defenses (catalase, glutathione peroxidase, etc.) appear to be simultaneously down regulated in old age by a major regulatory gene known as a codon. Pharmacological doses of vitamin E “leans against” this deficiency by external (“exogenous”) replacement of lost free radical defenses.
(c) In a large clinical and investigational literature, vitamin E has been clearly and unequivocally documented to improve immune function. The effect is common to most plant origin (phytochemical) antioxidants